Cara Therapeutics is a leading biopharmaceutical company based in Shelton, CT, dedicated to transforming the treatment of chronic pruritus. With a focus on developing innovative therapies, their expert team is committed to providing relief for the millions of individuals suffering from this debilitating condition.
Driven by their mission to change lives, Cara Therapeutics has successfully launched the first and only approved product for moderate to severe intractable itch in patients undergoing hemodialysis. Additionally, they are actively advancing their late-stage program for Notalgia Paresthetica, a common neuropathic itch, with the aim of addressing the unmet needs of patients. Through their proprietary science and dedication to improving quality of life, Cara Therapeutics is revolutionizing the way pruritus is treated.
Generated from the website